tumor-immune microenvironment during neoadjuvant targeted therapy in her2-positive breast cancer
Published 5 years ago • 1.6K plays • Length 22:27Download video MP4
Download video MP3
Similar videos
-
10:56
spatial profiling reveals the immune landscape of breast cancer
-
7:15
characterizing the immune microenvironment before and following anti-her2 neoadjuvant therapy
-
22:50
neoadjuvant therapy for her2-positive breast cancer - dr. scott christensen
-
16:58
assessing immune biomarkers of response to anthracyclines in breast cancer
-
0:57
neohip: neoadjuvant her2-targeted therapy /- io with pembrolizumab
-
13:42
neoadjuvant immune therapy for er positive breast cancer – the time has come
-
4:50
overview of neoadjuvant therapy in her2 breast cancer
-
2:19
her2 heterogeneity and neoadjuvant therapy in breast cancer
-
3:28
neoadjuvant treatment strategies for her2-positive breast cancer
-
5:57
development and implementation of personalized cancer immunotherapy
-
1:04
dr. demichele on importance of neoadjuvant care in her2 breast cancer
-
6:45
her2 /er- breast cancer: neoadjuvant therapy options
-
5:28
neoadjuvant therapy for her2 breast cancer
-
2:15
dr. hurvitz on neoadjuvant therapy for her2 breast cancer
-
1:00
utilizing neoadjuvant immunotherapies in patients with er , her2- primary breast cancer
-
14:11
discovery of biomarkers for sensitivity to immunotherapy in melanoma and lung cancer
-
3:27
dr. tripathy on neoadjuvant treatment strategies in her2 breast cancer
-
5:03
consideration for neoadjuvant treatment in her2 invasive ductal carcinoma